Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia

European Journal of Cancer Prevention

Volumn 17, Issue 2, 2008, Pages 125-132

  Majumdar, Sunipa ^a   Mondal, Bama Charan ^a   Ghosh, Moloy ^b   Dey, Sarmistha ^b   Mukhopadhyay, Ashis ^c   Chandra, Sarmila ^d   Dasgupta, Uma B ^a,e  

^a UNIVERSITY OF CALCUTTA   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

^c Park Point Nursing Home   (India)

^d Kothari Medical Centre   (India)

^e Department of Biophysics Molecular Biology and Genetics ^*  (India)

Author keywords

Acute myeloid leukemia; Eastern India; Gene polymorphism; GSTM1; NAT2

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLELE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARYLAMINE N-ACETYLTRANSFERASE; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2D6; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; INCIDENCE; INDIA; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 39749105941     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3282b6fd68     Document Type: Article

References (34)

1. Agundez Jose AG (2004). Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 5:211-224.
2. Anitha A, Banerjee M (2003). Arylamine N-acetyltransferase 2 polymorphism in the ethnic populations of South India. Int J Mol Med 11:125-131.
3. Bland JM, Altman DG (2000). Statistics notes: the odds ratio. Br Med J 320:1468.
4. Bowen DT, Frew ME, Rollinson S, Raddam PL, Dring A, Smith MT, et al. (2003). CYP1A1*2B (Val) allele is over represented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication. Blood 101:2770-2774.
5. Cascorbi I, Brockmoller J, Roots IA (1996). C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages and impact on lung cancer susceptibility. Cancer Res 56:2965-2969.
6. D'Alo F, Voso MT, Guidi F, Massini G, Scardocci A, Sica S, et al. (2004). Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult myeloid leukemia. Haematologica 89:664-670.
7. Davies SM, Robinson LL, Buckley JD, Radloff GA, Ross JA, Perentesis JP (2000). Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children's Cancer Group Study. Cancer Epidemiol Biomarkers Prev 9:563-566.
8. Devasena A, Chaubal PC, Kannan S, Bhisey RA, Mahimkar MB (2007). Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis. [Epub ahead of print].
9. Dreschler B, Lubbert M (2006). Acute myeloid leukemia: epidemiology and etiology. Cancer 107:2099-2107.
10. Gonzales MV, Alvarez V, Pello MF, Menendez MJ, Suarez C, Coto E (1998). Genetic polymorphism of N-acetyltransferase 2, glutathione S-transferase-M1, and cytochromes P450IIEI and P450IID6 in the susceptibility to head and neck cancer. J Clin Pathol 4:294-298.
11. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, et al. (2000). Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms (Review). Cancer Epidemiol Biomarkers Prev 9:29-42.
12. Hengstler JG, Arand M, Herrero ME, Oesch F (1998). Polymorphism of N-acetyltransferases, glutathione-S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res 154:47-85.
13. Hirvonen A, Pelin K, Tammilehto L, Karjalainen A, Mattson K, Linnainmaa K (1995). Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res 55:2981-2983.
14. Hirvonen A, Saarikoski ST, Linnainmaa K, Koskinen K, Husgafvel-Pursiainen K, Mattson K, et al. (1996). Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 88:1853-1856.
15. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D (1999). Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1 and GSTT1 genetic polymorphisms. Blood 93:1496-1501.
16. Krajinovic M, Richer C, Sinnett H, Labuda D, Sinnett D (2000). Genetic polymorphisms of N-acetyltransferases 1and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 9:557-562.
17. Lemos MC, Cabrita FJ, Silva HA, Vivan M, Placido F, Regateiro FJ (1999). Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis 20:1225-1229.
18. Mishra DK, Kumar A, Srivastava DA, Mittal RD (2004). Allelic variation of GSTT1, GSTM1, and GSTP1 genes in North Indian population. Asian Pac J Cancer Prev 5:362-365.
19. Mondal BC, Paria N, Majumdar S, Mukhopadhyay A, Chaudhuri U, Dasgupta UB (2005). Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukemia. Eur J Cancer Prev 14:281-284.
20. Nakago S, Hadfield RM, Zondervan KT, Mardon H, Manek S, Weeks DE, et al. (2001). Association between endometriosis and N-acetyltransferase 2 polymorphisms in a UK population. Mol Hum Reprod 7:1079-1083.
21. Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, et al. (2000). Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia, myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 6:4091-4095.
22. Petersen DD, McKinney CE, Ikeya K, Smith HH, Bale AE, McBride OW, et al. (1991). Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 48:720-725.
23. Raddam PL, Rollinson S, Kane E, Roman E, Moorman A, Cartwright R, et al. (2000). Poor metabolises at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukemia. Pharmacogenetics 10:605-615.
24. Rollinson S, Roddam P, Kane E, Roman E, Cartwright R, Jack A, Morgan GJ (2000). Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukemia. Carcinogenesis 21:43-47.
25. Rollinson S, Raddam PL, Willett E, Roman E, Cartwright R, Jack A, et al. (2001). Nat2 acetylator genotypes confer no effect on the risk of developing adult acute leukemia. Cancer Epidemiol Biomarkers Prev 10:567-568.
26. Roy B, Majumdar PP, Dey B, Chakraborty M, Banerjee S, Roy M, et al. (2001). Ethnic differences in distributions of GSTM1 and GSTT1 homozygous 'null' genotypes in India. Hum Biol 73:443-450.
27. Sayitoglu MA, Hatirnaz O, Erensoy N, Ozbek U (2006). Role of CYP2D6, CYP1A1, CYP2E1, GSTT1 and GSTM1 genes in the susceptibility to acute leukemias. Am J Hematol 81:162-170.
28. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A (2004). Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem 266:1-9.
29. Song N, Tan W, Xing D, Lin D (2001). CYP1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis 22:11-16.
30. Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, Pillai MR (2001). Genetic polymorphism of CYPA1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 37:593-598.
31. Srivastava DSL, Mittal RD (2005). Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population. BioMed Cent Urol 5:12.
32. Strange RC, Fryer AA (1999). The glutathione S-transferases: influence of polymorphism on cancer susceptibility. LARC Sci Publ 148:231-249.
33. Suryanarayana V, Deenadayal M, Singh L (2004). Association of CYP1A1 gene polymorphism with recurrent pregnancy loss in South Indian population. Hum Reprod 19:2648-2652.
34. Wolf CR, Smith CA, Gough AC, Moss JE, Vallis KA, Howard G, et al. (1992). Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. Carcinogenesis 13:1035-1038.